Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-049873

Chief Financial Officer sold 20,000 shares at $36.17 ($723,400)

  • Chief Financial Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2020-09-08 Option exercise +20,000 $6.32 $126,400 21,000 D
Cohen Chad M Chief Financial Officer 2020-09-08 Sale −20,000 $36.17 $723,400 1,000 D
Derivatives
Cohen Chad M Chief Financial Officer 2020-09-08 Option exercise · Stock Option (Right To Buy) −20,000 590,000 D
Open-market sales · 20,000 sh · avg $36.17 · $723,400
Loading xslF345X03/doc4.xml…